002821 凯莱英
午间休市 07-30 11:30:00
资讯
新帖
简况
China Southern Asset Management Co., Ltd. (南方基金管理股份有限公司)增持凯莱英(06821)10.97万股 每股作价约120.18港元
智通财经 · 07-23
China Southern Asset Management Co., Ltd. (南方基金管理股份有限公司)增持凯莱英(06821)10.97万股 每股作价约120.18港元
凯莱英获小摩增持18.595万股 每股作价约130.86港元
新浪港股 · 07-22
凯莱英获小摩增持18.595万股 每股作价约130.86港元
7月17日凯莱英跌10.00%，红土创新医疗保健股票A基金重仓该股
证券之星 · 07-17
7月17日凯莱英跌10.00%，红土创新医疗保健股票A基金重仓该股
凯莱英(06821)AH齐跌 NorgesBank持股比例降至7.4%
金吾财讯 · 07-17
凯莱英(06821)AH齐跌 NorgesBank持股比例降至7.4%
Schroders PLC减持凯莱英(06821)20.80万股 每股作价约132.76港元
智通财经 · 07-16
Schroders PLC减持凯莱英(06821)20.80万股 每股作价约132.76港元
花旗集团在凯莱英H股的多头仓位从5.09%降至2.92%
美股速递 · 07-16
花旗集团在凯莱英H股的多头仓位从5.09%降至2.92%
凯莱英：公司A股股票交易异常波动
南方财经网 · 07-15
凯莱英：公司A股股票交易异常波动
7月15日龙虎榜机构席位买卖详情
南方财经网 · 07-15
7月15日龙虎榜机构席位买卖详情
7月15日凯莱英涨10.00%，红土创新医疗保健股票A基金重仓该股
证券之星 · 07-15
7月15日凯莱英涨10.00%，红土创新医疗保健股票A基金重仓该股
7月14日凯莱英涨7.63%，红土创新医疗保健股票A基金重仓该股
证券之星 · 07-14
7月14日凯莱英涨7.63%，红土创新医疗保健股票A基金重仓该股
医药外包概念股普涨 凯莱英(06821)升逾4% 机构指CXO反弹有望获业绩支撑
金吾财讯 · 07-14
医药外包概念股普涨 凯莱英(06821)升逾4% 机构指CXO反弹有望获业绩支撑
Schroders PLC减持凯莱英(06821)13.1万股 每股作价约114港元
智通财经 · 07-13
Schroders PLC减持凯莱英(06821)13.1万股 每股作价约114港元
凯莱英获小摩增持14.38万股 每股作价约111.63港元
新浪港股 · 07-12
凯莱英获小摩增持14.38万股 每股作价约111.63港元
凯莱英（002821）披露回购注销部分限制性股票减少注册资本公告，7月10日股价上涨2.59%
证券之星 · 07-10
凯莱英（002821）披露回购注销部分限制性股票减少注册资本公告，7月10日股价上涨2.59%
小摩增持凯莱英(06821)14.38万股 每股作价约111.63港元
智通财经网 · 07-10
小摩增持凯莱英(06821)14.38万股 每股作价约111.63港元
大行评级丨野村：上调药明康德、信达生物及凯莱英目标价，均维持“买入”评级
格隆汇 · 07-10
大行评级丨野村：上调药明康德、信达生物及凯莱英目标价，均维持“买入”评级
凯莱英遭Norges Bank减持20.91万股 每股作价112.2833港元
新浪港股 · 07-10
凯莱英遭Norges Bank减持20.91万股 每股作价112.2833港元
7月9日凯莱英涨7.82%，中欧医疗健康混合A基金重仓该股
证券之星 · 07-09
7月9日凯莱英涨7.82%，中欧医疗健康混合A基金重仓该股
凯莱英(06821)根据H股限制性股票计划授出合共2783.45万股激励股份
智通财经 · 07-08
凯莱英(06821)根据H股限制性股票计划授出合共2783.45万股激励股份
凯莱英（002821）披露2026年A股限制性股票激励计划（草案），7月8日股价下跌2.33%
证券之星 · 07-08
凯莱英（002821）披露2026年A股限制性股票激励计划（草案），7月8日股价下跌2.33%
加载更多
公司概况
公司名称：
凯莱英医药集团(天津)股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
发行价格：
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":143.3,"timestamp":1785387510000,"preClose":155.01,"halted":0,"volume":8427172,"delay":0,"changeRate":-0.0755,"floatShares":317000000,"shares":361000000,"eps":3.0775,"marketStatus":"午间休市","change":-11.71,"latestTime":"07-30 11:30:00","open":155.01,"high":155.01,"low":142.9,"amount":1251000000,"amplitude":0.0781,"askPrice":143.59,"askSize":1,"bidPrice":143.26,"bidSize":2,"shortable":0,"etf":0,"ttmEps":3.0775,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785387600000},"marketStatusCode":3,"adr":0,"adjPreClose":155.01,"symbolType":"stock","openAndCloseTimeList":[[1785375000000,1785382200000],[1785387600000,1785394800000]],"highLimit":170.51,"lowLimit":139.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360780970,"isCdr":false,"pbRate":3.12,"roa":"--","peRate":46.563769,"roe":"1.71%","epsLYR":3.16,"committee":-0.850467,"marketValue":51700000000,"turnoverRate":0.0266,"status":1,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":107.8,"timestamp":1785384300008,"preClose":116.3,"halted":0,"volume":470140,"delay":0,"premium":"-35.15"},"floatMarketCap":45432000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2653100744","title":"China Southern Asset Management Co., Ltd. (南方基金管理股份有限公司)增持凯莱英(06821)10.97万股 每股作价约120.18港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653100744","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653100744?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:01","pubTimestamp":1784804513,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月20日，China Southern Asset Management Co., Ltd. (南方基金管理股份有限公司)增持凯莱英(06821)10.97万股，每股作价120.1785港元，总金额约为1318.36万港元。增持后最新持股数目为141.73万股，最新持股比例为5.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU1328615791.USD","06821","BK0239","002821","EWH","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653784170","title":"凯莱英获小摩增持18.595万股 每股作价约130.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784170","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653784170?lang=zh_cn&edition=full","pubTime":"2026-07-22 08:30","pubTimestamp":1784680200,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，7月16日，小摩增持凯莱英（06821）18.595万股，每股作价130.859港元，总金额约为2433.32万港元。增持后最新持股数目约为234.71万股，最新持股比例为8.43%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-22/doc-iniirshq4735285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2213496289.HKD","LU0683600562.USD","LU2505996509.AUD","JPX","LU0256863902.USD","IXG","LU2456880835.USD","UYG","EWH","XLF","LU1496350502.SGD","IE000M9KFDE8.USD","JPMO","BK4588","KBWB","LU0265550946.USD","002821","LU1116320901.HKD","BK4566","TFNS","LU2592432038.USD","BK1191","LU2264538146.SGD","LU2746668461.USD","IYG","LU2106854487.HKD","IE00BDRTCR15.USD","06821","LU1894683264.USD","TRUF","LU0417517546.SGD","LU2237443465.HKD","FNCL","IYF","LU0640476718.USD","FTXO","LU2244417387.USD","JPO","SG9999002232.USD","LU2430703095.HKD","LU1363072403.SGD","BK4207","LU0820561909.HKD","LU0070302665.USD","IE00BJLML261.HKD","LU0345769128.USD","VFH","LU0106261372.USD","LU2552382058.USD","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406625","title":"7月17日凯莱英跌10.00%，红土创新医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652406625?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:45","pubTimestamp":1784277957,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日凯莱英跌10.00%，收盘报161.99元，换手率3.99%，成交量12.65万手，成交额20.88亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为红土创新基金的红土创新医疗保健股票A。红土创新医疗保健股票A目前规模为1.97亿元，最新净值1.4311，较上一交易日下跌2.24%，近一年上涨3.51%。红土创新医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1328615791.USD","002821","06821","BK0132","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652747246","title":"凯莱英(06821)AH齐跌 NorgesBank持股比例降至7.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652747246","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652747246?lang=zh_cn&edition=full","pubTime":"2026-07-17 13:36","pubTimestamp":1784266605,"startTime":"0","endTime":"0","summary":"金吾财讯 | 凯莱英(06821)盘中持续走低，午后跌幅进一步扩大，截至发稿，最新报1125.20港元，跌幅10.49%，成交额7529.75万港元。对应A股(002821)同步下跌9.99%，最新报161.99元人民币，成交额18.53亿元人民币。消息面上，港交所新近文件披露，NorgesBank已于7月14日减持凯莱英20.76万股，每股均价127.6543港元，涉资约2650.1万港元。减持后，NorgesBank最新持股数目为206.06万股，持股比例由8.15%下降至7.40%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986142","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","BK0132","LU1328615791.USD","06821","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449909","title":"Schroders PLC减持凯莱英(06821)20.80万股 每股作价约132.76港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449909","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651449909?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:15","pubTimestamp":1784200535,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月15日，Schroders PLC减持凯莱英(06821)20.80万股，每股作价132.7607港元，总金额约2761.42万港元。减持后最新持股数目约为352.45万股，持股比例为12.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0132","LU1328615791.USD","06821","EWH","002821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169582849","title":"花旗集团在凯莱英H股的多头仓位从5.09%降至2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169582849","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169582849?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:26","pubTimestamp":1784193973,"startTime":"0","endTime":"0","summary":"根据香港交易所披露的信息，花旗集团持有的凯莱英H股好仓（多头）仓位比例在7月10日出现显著下降，从原先的5.09%减少至2.92%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002821","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146812","title":"凯莱英：公司A股股票交易异常波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146812","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651146812?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:55","pubTimestamp":1784116500,"startTime":"0","endTime":"0","summary":"南财智讯7月15日电，凯莱英（002821）公告，公司股票于2026年7月13日至7月15日连续三个交易日内收盘价格涨幅偏离值累计超过20%，根据深圳证券交易所相关规定，属于股票交易异常波动情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807657675.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807657675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159982","BK0239","BK1191","LU1328615791.USD","BK0132","002821","399300","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651567894","title":"7月15日龙虎榜机构席位买卖详情","url":"https://stock-news.laohu8.com/highlight/detail?id=2651567894","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651567894?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:18","pubTimestamp":1784107080,"startTime":"0","endTime":"0","summary":"南财智讯7月15日电，盘后数据显示，因当日异动登上龙虎榜的个股中，34只沪深A股龙虎榜出现了机构的身影，机构合计净买入30394.26万元，具体来看，机构净买入19只个股，净卖出15只个股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807534381.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807534381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0214","BK0229","BK0188","BK0198","BK0132","LU1979443071.USD","BK0028","BK0125","002185","300821","LU1934453819.USD","688192","BK0197","603459","002558","BK0121","LU1328615791.USD","BK0239","BK0094","BK0217","BK0196","002821","BK0139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453715","title":"7月15日凯莱英涨10.00%，红土创新医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651453715?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:31","pubTimestamp":1784104299,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日凯莱英涨10.00%创60日新高，收盘报195.75元，换手率7.09%，成交量22.47万手，成交额42.4亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为红土创新基金的红土创新医疗保健股票A。红土创新医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","06821","BK1191","002821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651173065","title":"7月14日凯莱英涨7.63%，红土创新医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651173065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651173065?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:28","pubTimestamp":1784017728,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日凯莱英涨7.63%，收盘报177.95元，换手率5.69%，成交量18.05万手，成交额30.66亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为红土创新基金的红土创新医疗保健股票A。红土创新医疗保健股票A目前规模为1.97亿元，最新净值1.3931，较上一交易日下跌2.14%，近一年上涨5.34%。红土创新医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821","BK0132","BK1191","LU1328615791.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651386126","title":"医药外包概念股普涨 凯莱英(06821)升逾4% 机构指CXO反弹有望获业绩支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2651386126","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651386126?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:51","pubTimestamp":1783997504,"startTime":"0","endTime":"0","summary":"2026年Q2Orforglipron等外企重磅品种获批上市，继续支撑药明康德订单增长。药明康德主动回购也彰显对未来信心，截止2026年6月25日，已回购金额超过10亿元。从6月初至今，CXO板块在业绩和订单的支撑下，率先于创新药反弹。自6月8日至7月10日，CRO指数已反弹21.72%。展望下半年，创新药融资增长将继续支持CXO景气度延续。目前CRO龙头企业药明康德2027年预测PE为17.58X，凯莱英为33.19X。随着中期业绩临近，2季度订单趋势逐步明确，CXO反弹有望获得业绩支撑。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985793","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1242518857.USD","09939","KURE","LU0039217434.USD","06127","LU0348825331.USD","LU0456846285.SGD","BK1583","LU2045819591.USD","BK0239","LU0516422952.EUR","LU0708995583.HKD","LU0348735423.USD","IE00B0JY6N72.USD","LU1794554557.SGD","LU1720050803.USD","03759","02359","BK1191","LU0043850808.USD","LU0856984785.SGD","002821","LU0456827905.SGD","CXO","BK1574","06821","LU0516423091.SGD","LU0181495838.USD","BK0132","LU0326950275.SGD","02269","BK1515","BK1576","BK1521","LU0051755006.USD","LU0417516738.SGD","LU1046422090.SGD","LU3063872942.SGD","LU2125910500.SGD","LU1688375341.USD","LU0979878070.USD","SG9999002463.SGD","LU2242644610.SGD","LU0327786744.USD","03347","LU0823426480.USD","159938","LU0516422366.SGD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116977","title":"Schroders PLC减持凯莱英(06821)13.1万股 每股作价约114港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116977","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651116977?lang=zh_cn&edition=full","pubTime":"2026-07-13 19:21","pubTimestamp":1783941676,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，7月9日，Schroders PLC减持凯莱英(06821)13.1万股，每股作价114.0024港元，总金额约为1493.43万港元。减持后最新持股数目为416.81万股，最新持股比例为14.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK1191","LU1328615791.USD","06821","002821","EWH","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650168836","title":"凯莱英获小摩增持14.38万股 每股作价约111.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650168836","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650168836?lang=zh_cn&edition=full","pubTime":"2026-07-12 15:30","pubTimestamp":1783841400,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，7月7日，小摩增持凯莱英（06821）14.38万股，每股作价111.632港元，总金额约为1605.27万港元。增持后最新持股数目约为255.33万股，最新持股比例为9.17%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-12/doc-inihpucz4585345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BHPRN162.USD","LU0149725797.USD","IYF","LU1670627923.USD","LU0345769631.USD","IE00BYXW3230.USD","IE00BWXC8680.SGD","LU2237443465.HKD","IE0034235303.USD","LU2430703095.HKD","LU2505996509.AUD","BK0239","UYG","XLF","LU0689472784.USD","LU1974910355.USD","LU0345770308.USD","LU0787776722.HKD","LU0256863902.USD","LU2430703251.USD","KBWB","EWH","LU2244417387.USD","LU2746668974.SGD","LU0234572021.USD","LU1894683264.USD","LU2242649171.HKD","LU2552382058.USD","JPO","JPX","FNCL","VFH","LU2746668461.USD","BK4581","002821","IE00BKVL7J92.USD","LU0310799852.SGD","FTXO","JPMO","IE00BJLML261.HKD","LU0256863811.USD","LU0106831901.USD","06821","IXG","LU0170899867.USD","BK4207","IYG","LU0267386448.USD","LU1988902786.USD","LU2756315664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650398135","title":"凯莱英（002821）披露回购注销部分限制性股票减少注册资本公告，7月10日股价上涨2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650398135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650398135?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:04","pubTimestamp":1783692268,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，凯莱英报收于165.41元，较前一交易日上涨2.59%，最新总市值为596.77亿元。近日，凯莱英医药集团（天津）股份有限公司发布《关于回购注销限制性股票激励计划部分限制性股票减少注册资本暨通知债权人的公告》。公告显示，因2025年限制性股票激励计划中11名首次授予激励对象及4名预留授予激励对象离职，公司拟回购注销其已获授但尚未解除限售的117,500股A股限制性股票。本次回购注销后，公司总股本将由360,780,970股变更为360,663,470股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","BK0132","LU1328615791.USD","BK0239","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650030182","title":"小摩增持凯莱英(06821)14.38万股 每股作价约111.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650030182","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650030182?lang=zh_cn&edition=full","pubTime":"2026-07-10 19:17","pubTimestamp":1783682253,"startTime":"0","endTime":"0","summary":"7月7日，小摩增持凯莱英(06821)14.38万股，每股作价111.632港元，总金额约为1605.27万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260710/20260710191811_40394.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260710/20260710191811_40394.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0211328371.USD","IXG","JPX","LU1244550577.SGD","LU0070302665.USD","IE00BDRTCR15.USD","BK4534","LU0976567544.SGD","VFH","06821","IYF","BK4533","LU1974910355.USD","LU0215105999.USD","LU2592432038.USD","JPMO","LU0211331839.USD","LU1914381329.SGD","LU2211815571.USD","FTXO","IYG","LU0417517546.SGD","LU2237443465.HKD","LU1894683264.USD","LU0106831901.USD","EWH","FNCL","LU0820562030.AUD","LU1988902786.USD","LU0251132253.USD","IE00BYXW3230.USD","LU1064131342.USD","LU1280957306.USD","LU2237443978.SGD","LU2746668974.SGD","BK1191","LU2237443895.HKD","LU0310799852.SGD","IE00BKVL7J92.USD","BK4581","XLF","UYG","002821","LU0106261372.USD","LU2430703095.HKD","JPO","KBWB","IE00B3S45H60.SGD","BK0239","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650902158","title":"大行评级丨野村：上调药明康德、信达生物及凯莱英目标价，均维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2650902158","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650902158?lang=zh_cn&edition=full","pubTime":"2026-07-10 14:26","pubTimestamp":1783664798,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2097828557.USD","LU0502904849.HKD","LU1251922891.USD","BK1161","LU1719994722.HKD","HK0000165453.HKD","KURE","LU0611395673.USD","LU1934453819.USD","LU1979443071.USD","BK1141","603259","BK1583","BK0239","LU2045819591.USD","BK1589","LU0708995583.HKD","LU2097828474.EUR","LU1969619763.USD","LU2097828714.EUR","LU1328615791.USD","02359","LU0320764599.SGD","BK1191","LU0455707207.USD","LU1997244956.HKD","LU2495084118.USD","IE00B543WZ88.USD","002821","IE00B5MMRT66.SGD","LU0052750758.USD","LU2097828805.USD","IE00BPRC5H50.USD","LU0348766576.USD","LU0456842615.SGD","LU1997245177.USD","LU0348767384.USD","BK0132","01801","LU1303224171.USD","BK1576","LU1046422090.SGD","LU2097828631.EUR","LU1770034418.SGD","LU2125910500.SGD","LU2328871848.SGD","LU2242644610.SGD","BK0216","06821","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650970205","title":"凯莱英遭Norges Bank减持20.91万股 每股作价112.2833港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650970205","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650970205?lang=zh_cn&edition=full","pubTime":"2026-07-10 08:06","pubTimestamp":1783641960,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新数据显示，7月7日，Norges Bank减持凯莱英（06821）20.91万股，每股作价112.2833港元，总金额约为2347.84万港元。减持后最新持股数目为245.69万股，持股比例为8.83%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-10/doc-inihhkuh7227632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ENOR","BK0239","BK1191","06821","EWH","LU1328615791.USD","002821","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650942710","title":"7月9日凯莱英涨7.82%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650942710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650942710?lang=zh_cn&edition=full","pubTime":"2026-07-09 16:27","pubTimestamp":1783585624,"startTime":"0","endTime":"0","summary":"证券之星消息，7月9日凯莱英涨7.82%，收盘报161.23元，换手率4.87%，成交量15.45万手，成交额24.29亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.8455，较上一交易日下跌2.46%，近一年上涨7.42%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900028377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0239","159760","BK1191","002821","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991153","title":"凯莱英(06821)根据H股限制性股票计划授出合共2783.45万股激励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991153","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649991153?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:08","pubTimestamp":1783519733,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2026年7月8日，根据H股限制性股票计划，本公司向若干雇员参与者授出合共2783.45万股激励股份(该授出)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","002821","BK1191","LU1328615791.USD","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649499143","title":"凯莱英（002821）披露2026年A股限制性股票激励计划（草案），7月8日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649499143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649499143?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:06","pubTimestamp":1783519581,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，凯莱英报收于149.53元，较前一交易日下跌2.33%，最新总市值为539.48亿元。近日，凯莱英医药集团（天津）股份有限公司发布2026年A股限制性股票激励计划（草案），拟授予限制性股票338.80万股，占公司A股股本总额的1.02%，其中首次授予271.10万股，预留67.70万股。本计划有效期最长不超过72个月，解除限售期分为四个阶段，每期解除限售比例均为25%。业绩考核以2025年营业收入和净利润为基数，设定逐年增长目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK1191","LU1328615791.USD","159982","06821","002821","399300"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785387556288,"stockEarnings":[{"period":"1week","weight":-0.0564},{"period":"1month","weight":-0.0759},{"period":"3month","weight":0.2452},{"period":"6month","weight":0.5771},{"period":"1year","weight":0.2722},{"period":"ytd","weight":0.6824}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0602},{"period":"3month","weight":-0.069},{"period":"6month","weight":-0.0703},{"period":"1year","weight":0.0606},{"period":"ytd","weight":-0.0354}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36078万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}